ropivacaine hydrochloride
Generic: ropivacaine hydrochloride
Labeler: mylan institutional llcDrug Facts
Product Profile
Brand Name
ropivacaine hydrochloride
Generic Name
ropivacaine hydrochloride
Labeler
mylan institutional llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ropivacaine hydrochloride 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
67457-798
Product ID
67457-798_78b68980-9e8d-4f38-ba2a-a9d520451f5d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206091
Listing Expiration
2026-12-31
Marketing Start
2024-03-18
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67457798
Hyphenated Format
67457-798
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ropivacaine hydrochloride (source: ndc)
Generic Name
ropivacaine hydrochloride (source: ndc)
Application Number
ANDA206091 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 10 POUCH in 1 CARTON (67457-798-99) / 1 BAG in 1 POUCH (67457-798-10) / 100 mL in 1 BAG
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["EPIDURAL", "INFILTRATION", "PERINEURAL"], "spl_id": "78b68980-9e8d-4f38-ba2a-a9d520451f5d", "openfda": {"upc": ["0367457798103", "0367457799209"], "unii": ["V910P86109"], "rxcui": ["1734347", "1734355"], "spl_set_id": ["9e1d1b15-c224-4ff4-a39d-3b9cebfc8403"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CARTON (67457-798-99) / 1 BAG in 1 POUCH (67457-798-10) / 100 mL in 1 BAG", "package_ndc": "67457-798-99", "marketing_start_date": "20240318"}], "brand_name": "ROPIVACAINE HYDROCHLORIDE", "product_id": "67457-798_78b68980-9e8d-4f38-ba2a-a9d520451f5d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "67457-798", "generic_name": "ROPIVACAINE HYDROCHLORIDE", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ROPIVACAINE HYDROCHLORIDE", "active_ingredients": [{"name": "ROPIVACAINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA206091", "marketing_category": "ANDA", "marketing_start_date": "20240318", "listing_expiration_date": "20261231"}